EMA 'Dear Doctor' letter to fix Takeda's Velcade errors
This article was originally published in Scrip
Executive Summary
The European Medicines Agency (EMA) is recommending the gradual withdrawal from the market of all medicines containing meprobamate, a sedative medicine that was a precursor of the benzodiazepines. The agency's Committee for Medicinal Products for Human Use (CHMP) made the recommendation after an EU review was triggered by the French authorities' decision in July 2011 to suspend marketing authorisations for oral versions of the drug.